News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Abstract submission open for the inaugural AACR IO Conference
AACR/LinkedIn
Oct 8, 2024, 10:53

Abstract submission open for the inaugural AACR IO Conference

American Association for Cancer Research (AACR) shared on LinkedIn:

“Submit an abstract by November 13 for the inaugural AACR IO Conference on Discovery and Innovation in Cancer Immunology.

The conference, which is chaired by Antoni Ribas, will take place February 23-26, 2025, in Los Angeles. Learn more.”

More posts featuring AACR on oncodaily.com

 

AACR AACR IO Conference Antoni Ribas cancer cancer immunology OncoDaily Oncology
Special Coverage
Career
Jan 20, 2025, 03:10
Lawrence “Larry” Deist Appointed to Board of Directors at Rally Foundation for Childhood Cancer Research
Blog
Jan 20, 2025, 02:54
Drew Moghanaki: A new medical oncology position at the VA Medical Center in Long Beach
Science
Jan 20, 2025, 02:44
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL
Science
Jan 20, 2025, 02:16
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer
Blog
Jan 20, 2025, 02:14
Akriti Jain: Grateful to present at Cleveland Clinic ASH review
Career
Jan 19, 2025, 23:12
Kimryn Rathmell Steps Down as NCI Director, Concluding a Pivotal Leadership Era
Blog
Jan 19, 2025, 23:07
Antonio D'Alessio: Our work on neoadjuvant ICI in HCC has been chosen for the 2025 ASCO GI Merit Award
Science
Jan 19, 2025, 22:56
Bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab in pleural mesothelioma
Insight
Jan 19, 2025, 22:04
Chiaojung Jillian Tsai: TACE combined with Lenvatinib and Pembrolizumab vs Placebo for HCC
Science
Jan 19, 2025, 21:01
The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT)
Science
Jan 19, 2025, 20:59
Psychosocial impact associated with a multicancer early detection test (PATHFINDER)
Blog
Jan 19, 2025, 15:36
Paolo Tarantino: How do you plan to use Datopotamab Deruxtecan for HR+/HER2- MBC?